Empagliflozin vs Lithium Carbonate

Empagliflozin vs Lithium Carbonate: Overview

This comparison examines the pharmacological differences between Empagliflozin and Lithium Carbonate.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Lithium Carbonate: Modulates intracellular signaling via inositol and GSK-3 inhibition.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Lithium Carbonate — 18-36 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Lithium Carbonate — Li2CO3.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Lithium Carbonate — 73.8910 g/mol.

Type: Empagliflozin — Small molecule; Lithium Carbonate — Small molecule.